Company profile

GI Innovation, Inc.

358570 · KOSDAQ

Public Market Listing

358570KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for GI Innovation, Inc. are available on Yahoo Finance.

External market data link · No third-party exchange redistribution

Assets

(3 total)

3Total Assets

0Approved

0Phase 3 / Filed

3Phase 1–2 / Early

1Diseases

Showing 3 of 3 assets

		Target & Modality
GI-101	Phase 1/2	CTLA-4 / IL-2RβγProtein / enzyme therapeutic	Non-Small Cell Lung Cancer
GI-101A	Phase 1/2	CTLA-4 / IL-2RβγMultispecific antibody	Non-Small Cell Lung Cancer
GI-108	Phase 1/2	CD73 / IL-2RβγMultispecific antibody	Non-Small Cell Lung Cancer

Research

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Research

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.